AJP - Heart Calcium Transients and Cell-Sarcomere
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 281: H2256-H2260, 2001;
0363-6135/01 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (17)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Borutaite, V.
Right arrow Articles by Brown, G. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Borutaite, V.
Right arrow Articles by Brown, G. C.
Vol. 281, Issue 6, H2256-H2260, December 2001

SPECIAL TOPIC
Reversible inhibition of cellular respiration by nitric oxide in vascular inflammation

Vilmante Borutaite1, Anita Matthias1, Hatty Harris1, Salvador Moncada2, and Guy C. Brown1

1 Department of Biochemistry, University of Cambridge, Cambridge CB2 1QW; and 2 Wolfson Institute for Biomedical Research, University College London, London WC1E 6BT, United Kingdom


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Incubation of rat aortas with endotoxin and interferon-gamma for 24 h resulted in an aortic oxygen consumption that was substantially inhibited and strongly oxygen dependent (37% inhibition at 160 µM O2 and 62% inhibition at 80 µM O2 relative to untreated aortas). This respiratory inhibition was reversed by a nitric oxide (NO) scavenger (oxyhemoglobin) or by an inhibitor of inducible NO synthase [N-(3-(aminomethyl)benzyl)acetamide · 2HCl, 1400W], but not by an inhibitor of soluble guanylate cyclase (1H-[1,2,4]oxadiazolo[4,3-a]-quinoxalin-1-one). Addition of 1 µM NO to untreated aortas caused rapid and reversible inhibition of oxygen consumption that was greater at lower oxygen concentrations. Incubation of endothelial cells isolated from rat aortas with endotoxin and interferon-gamma for 24 h resulted in a steady-state NO concentration of ~0.5 µM and 90% inhibition of cellular oxygen consumption that was immediately reversed by an NO scavenger (oxyhemoglobin). These results suggest that during inflammation and sepsis, tissue respiration may be substantially reduced due to inhibition by NO of cytochrome oxidase.

aorta; endothelial cells; mitochondria; inducible nitric oxide synthase; oxygen


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

NITRIC OXIDE (NO) can regulate oxygen supply to tissues by activating soluble guanylate cyclase in vascular smooth muscle, resulting in vascular relaxation and increased blood flow (16, 23). However, NO can also potentially regulate tissue oxygen consumption by binding to the oxygen-binding site of cytochrome oxidase, resulting in reversible inhibition of mitochondrial respiration (5, 7, 9, 31). Binding of NO to cytochrome oxidase is competitive with oxygen, and at physiological levels of oxygen in tissue (roughly 30 µM O2) half-maximal inhibition of respiration occurs at 60 nM NO (7). This concentration is similar to that required for half-maximal activation of soluble guanylate cyclase (45 nM NO) (1). Higher concentrations of NO or its derivatives peroxynitrite and S-nitrosothiols can irreversibly inhibit respiration at multiple sites within mitochondria (4, 10, 14, 15, 20, 26). Reversible inhibition of oxygen consumption by NO has been found in isolated cytochrome oxidase (7, 13, 40), mitochondria (9, 25, 31), and cultured cells (6, 11, 19). In vivo it has been observed that inhibitors of NO synthase cause large increases in tissue and whole body oxygen consumption that are not attributable to any changes in vascular supply (17, 18, 21, 22, 33, 34), suggesting that basal release of NO tonically inhibits tissue respiration in vivo (41, 42). However, it is unclear whether any such NO inhibition of tissue respiration is mediated by a direct action of NO on mitochondrial respiration or indirectly, e.g., via cGMP.

Induction of the inducible isoform of NO synthase (iNOS) by endotoxin and cytokines results in a high, sustained concentration of NO (27), giving rise to reversible inhibition of cellular respiration rate in astrocytes (6) and cells coincubated with iNOS-expressing macrophages (8). iNOS expression also causes irreversible inhibition of mitochondrial respiratory components in astrocytes (3), hepatocytes (36), tumor cells (15, 37), and vascular smooth muscle cells (12, 38).

During local inflammation or the systemic inflammation of sepsis, iNOS is induced in a wide range of tissue cells (29, 30). Sepsis or endotoxemia can cause hypotension, vascular insufficiency, lactic acidosis, and multiple organ failure, and these symptoms have been associated with excessive NO production from iNOS (29, 30, 39). Mitochondrial dysfunction has also been implicated in sepsis, and in principle septic symptoms could be due to NO inhibition of mitochondrial respiration alone (28, 32). We set out to test 1) whether the induction of iNOS in the aorta and endothelial cells by endotoxin and interferon-gamma would result in a significant inhibition of respiration, and 2) the mechanism of any such inhibition, its reversibility, and sensitivity to oxygen concentration.


    METHODS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Wistar rats (12-16 wk old) were euthanized with CO2. Thoracic aortas were removed, cleaned of adhering fat and connective tissue in Hanks' balanced salt solution supplemented with 5 µM indomethacin, and cut into ~4-mm rings. Rings were incubated for 24 h at 37°C in DMEM (without serum) plus 500 IU/ml penicillin and streptomycin in an incubator gassed with 95% air-5% CO2. Alternatively, to induce iNOS, aortic rings were incubated for 24 h in DMEM (plus 500 IU/ml penicillin and 500 IU/ml streptomycin) supplemented with 10 µg/ml lipopolysaccharide (LPS endotoxin from Salmonella typhimurium; Sigma) and 50 U/ml interferon-gamma . For measurement of respiratory rate, aortic rings were washed with Krebs buffer, mounted on steel hooks, and put into 1 ml of Krebs-HEPES buffer (in mM: 118 NaCl, 4.8 KCl, 1.2 KH2PO4, 1.2 MgSO4, 1 CaCl2, 11 glucose, and 25 HEPES, pH 7.4) plus 0.5 mM L-arginine. Oxygen consumption by aortic rings was measured in a sealed and stirred vessel with a Clarke-type oxygen electrode built into the bottom of the vessel (Rank Brothers, Bottisham) maintained at 37°C.

Endothelial cells were isolated from rat aortas by digestion (7 min at 37°C) with 3 mg/ml collagenase (Sigma C-0130) in medium 199 and cultured in DMEM plus 15% fetal calf serum, 5 ng/ml basic fibroblast growth factor, 500 IU/ml penicillin, and 500 IU/ml streptomycin in an incubator gassed with 95% air-5% CO2 at 37°C. Respiratory measurements were made on 7-9th passage cultures that were ~80% confluent. Cells were activated by adding 10 µg/ml LPS (endotoxin from S. typhimurium, Sigma) and 50 U/ml interferon-gamma to the cultures for 24 h before respiratory measurements. To measure oxygen consumption, cells were removed from culture flasks by gentle scraping and centrifuged and resuspended at ~3 million cells per millimeter in the Krebs-HEPES buffer (content given above) plus 0.1 mM L-arginine. Of this cell suspension, 0.7 ml was added to a sealed, stirred vessel containing both oxygen and NO (World Precision Instruments) electrodes maintained at 37°C (7). The NO electrode was calibrated with NO-saturated, deoxygenated water, assuming this contains 2 mM NO (6).


    RESULTS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

We tested whether the induction of iNOS in rat aortic rings by endotoxin and interferon-gamma would inhibit aortic oxygen consumption. Figures 1 and 2 show that the oxygen consumption of rings maintained in culture conditions with endotoxin and interferon-gamma for 24 h was strongly inhibited relative to rings cultured in the absence of endotoxin and interferon-gamma . Moreover, the oxygen consumption of endotoxin- and interferon-gamma -treated rings became strongly oxygen dependent, so that the rate of oxygen consumption was almost proportional to oxygen concentration over the physiological range up to 160 µM O2 (Figs. 1 and 2). Reoxygenation of hypoxic rings returned the oxygen consumption rate to the previous high, normoxic rate (data not shown). In contrast, the oxygen consumption of untreated rings was relatively oxygen independent, remaining linear until low oxygen levels were reached (Figs. 1 and 2).


View larger version (8K):
[in this window]
[in a new window]
 
Fig. 1.   Representative traces showing oxygen consumption by aortic rings. Five aortic rings (13-19 mg wet wt) were incubated in 1 ml Krebs-HEPES buffer containing 0.5 mM L-arginine. Traces b and d, control aorta; trace c, aorta treated with lipopolysaccharide (LPS)-interferon-gamma ; trace a, LPS-interferon-gamma -treated aorta preincubated 1 h with 100 µM N-(3-(aminomethyl)benzyl)acetamide (1400W). Where indicated, aliquots of 1 µM nitric oxide (NO) were added to control aorta causing immediate but reversible inhibition of respiration. Horizontal dotted line, zero level of oxygen. Representative traces are of at least 3 experiments in each condition.



View larger version (23K):
[in this window]
[in a new window]
 
Fig. 2.   LPS-interferon-gamma -induced inhibition of respiration rate of aortic rings is oxygen dependent and is reversed by oxyhemoglobin (HbO2) or 1400W but not by ODQ. Experimental conditions were as in Fig. 1. Aortic rings were preincubated for 5 min with 10 µM ODQ or for 1 h with 100 µM 1400W; 10 µM HbO2 was added immediately before measuring oxygen consumption by aorta. Data are means ± SE of at least 3 experiments. *Statistically significant effect if compared with control at the same oxygen concentration.

To test whether the inhibition of respiration was rapidly reversible and due to NO, we added either a NO scavenger (oxyhemoglobin) or an iNOS inhibitor [N-(3-(aminomethyl)benzyl)acetamide · 2HCl, 1400W] to the endotoxin- and interferon-gamma treated rings before measuring oxygen consumption. These additions resulted in reversal of the respiratory inhibition (Figs. 1 and 2), indicating that the inhibition of oxygen consumption was rapidly reversible and due to NO from iNOS.

Because most of the physiological effects of NO are mediated by stimulation of soluble guanylate cyclase, we tested whether a specific inhibitor of this enzyme (1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one, ODQ) could reverse the inhibition of respiration in endotoxin- and interferon-gamma -treated rings. ODQ did not reverse the respiratory inhibition (Fig. 2), indicating that the NO inhibition of respiration was not mediated by cGMP.

To test whether NO alone could cause respiratory inhibition, we added authentic NO (1 µM) to control rings. This caused an immediate inhibition of aortic respiration, which completely reversed, however, during several minutes (Fig. 1), indicating that NO is a potent, reversible inhibitor of aortic respiration. Moreover, NO inhibition of aortic respiration was greater at lower oxygen concentrations (Fig. 1) and was insensitive to the soluble guanylate cyclase inhibitor ODQ (data not shown). All of these results in aortic rings are consistent with endotoxin and interferon-gamma causing inhibition of aortic respiration via NO inhibition of cytochrome oxidase in competition with oxygen.

We further tested whether induction of iNOS in aortic endothelial cells in culture would result in significant inhibition of cellular respiration and whether any such inhibition would be reversible. Figures 3 (representative traces) and 4 (mean data) show that endothelial cells activated for 24 h with endotoxin and interferon-gamma produced NO in the presence of L-arginine (steady-state concentration of 0.54 ± 0.11 µM NO) and that cellular respiration was substantially inhibited relative to untreated cells (92% inhibition). This inhibition was immediately reversed on addition of the NO scavenger oxyhemoglobin. This is again consistent with NO from iNOS causing potent but reversible inhibition of cellular respiration via NO binding to cytochrome oxidase.


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 3.   LPS-interferon-gamma activation of endothelial cells causes NO production and inhibition of cellular respiration, reversed by HbO2. Rat aortic endothelial cells were cultured without (control, A) or with (B) LPS-interferon-gamma for 24 h. Then, 3.1 million cells (LPS-interferon-gamma treated) or 3.8 million cells (control) were resuspended in 0.7 ml Krebs-HEPES plus 0.1 mM L-arginine and placed in a sealed, stirred vessel with NO and oxygen electrodes. HbO2 (10 µM) was subsequently added to remove the NO.



View larger version (18K):
[in this window]
[in a new window]
 
Fig. 4.   LPS-interferon-gamma activation of endothelial cells causes inhibition of cellular respiration, reversed by HbO2: pooled results. Values are means ± SE of 3 separate experiments measuring the oxygen consumption rate at 25-35% of oxygen saturation for control and LPS-interferon-gamma -treated cells (immediately before and after addition of oxyhemoglobin). *Statistically significant difference from control; # statistically significant difference from LPS-interferon-gamma -treated aortas in the absence of HbO2.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

We have shown here that incubation with endotoxin and interferon-gamma causes a substantial inhibition of oxygen consumption in both isolated aortas and aortic endothelial cells. This inhibition is largely or completely reversible by an NO scavenger or iNOS inhibitor, suggesting that NO from iNOS is reversibly inhibiting respiration.

Treatment of mice with endotoxin has previously been shown to reduce myocardial oxygen consumption ex vivo, an effect that was reversed by addition of an inhibitor of NO synthase (24). This inhibition of respiration did not occur in animals that were knockout for iNOS (24).

We have also shown that addition of 1 µM authentic NO causes rapid and reversible inhibition of aortic respiration, which is greater at lower oxygen concentrations. The NO-induced inhibition of respiration is likely to be due to NO binding to cytochrome oxidase, because we have previously shown that this causes rapid, reversible inhibition that is competitive with oxygen and occurs over the range of NO concentrations used here (5, 7). This is also consistent with the finding that endotoxin- and interferon-gamma -treated aortic rings have an oxygen consumption rate that is almost proportional to oxygen level, whereas untreated rings or treated rings supplemented with an NO scavenger or iNOS inhibitor have oxygen consumption rates that are relatively insensitive to oxygen level.

It has previously been found that endotoxin and interferon-gamma treatment of cultured vascular smooth muscle cells for 48 h resulted in an irreversible inhibition of mitochondrial respiration, attributed to activation of poly-ADP ribosyltransferase (PARS or PARP) and subsequent NAD+ and ATP depletion (38). However, in the conditions of our experiments, we found no significant irreversible inhibition of cellular respiration at 24 h, although this does not exclude such an inhibition appearing later or in different conditions. In particular, in vivo neutrophil recruitment and activation during inflammation may provide a source of superoxide from which peroxynitrite may be derived and which might cause an irreversible inhibition of respiration.

A substantial inhibition of cellular respiration by iNOS-derived NO in competition with oxygen has important implications for inflammation and sepsis. It has been suggested that tissue dysoxia during septic shock, and the consequent organ failure, may be due to inhibition of respiration by NO (24, 28, 32). Furthermore, although no experimental evidence is available at present, it is likely that inhibition of respiration also contributes to the vasodilatation and hyporeactivity to vasoconstrictors.

Inflammation and sepsis are known to be accompanied by glycolysis, increased production of lactate, and inhibition of tissue function (32, 35). Our present and previous findings suggest that these changes might indeed be due to inhibition of respiration by NO and the ensuing oxidative stress (2, 5, 8, 24).


    ACKNOWLEDGEMENTS

This work was supported by the Biotechnology and Biological Sciences Research Council and British Heart Foundation. S. Moncada was the recipient of an Medical Research Council grant.


    FOOTNOTES

Present address for A. Matthias: Dept. of Medicine, University of Queensland, Royal Brisbane Hospital, Herston 4029, Australia.

Address for reprint requests and other correspondence: V. Borutaite, Dept. of Biochemistry, Univ. of Cambridge, Tennis Court Rd., Cambridge CB2 1QW, UK (E-mail: vb207{at}mole.bio.cam.ac.uk).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Received 12 March 2001; accepted in final form 24 July 2001.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

1.   Bellamy, TC, and Garthwaite J. Sub-second kinetics of the nitric oxide receptor, soluble guanylate cyclase, in intact cerebellar cells. J Biol Chem 276: 4287-4292, 2001[Abstract/Free Full Text].

2.   Beltran, B, Mathur A, Duchen MR, Erusalimsky JD, and Moncada S. The effect of nitric oxide on cell respiration: a key to understanding its role in cell survival or death. Proc Natl Acad Sci USA 97: 14602-14607, 2000[Abstract/Free Full Text].

3.   Bolanos, JP, Peuchen S, Heales SJR, Land JM, and Clark JB. Nitric oxide-mediated inhibition of the mitochondrial respiratory chain in cultured astrocytes. J Neurochem 63: 910-916, 1994[ISI][Medline].

4.   Brown, GC. NO and mitochondrial respiration. Biochim Biophys Acta 1411: 351-369, 1999[Medline].

5.   Brown, GC. Regulation of mitochondrial respiration by nitric oxide inhibition of cytochrome c oxidase. Biochim Biophys Acta 1504: 46-57, 2001[Medline].

6.   Brown, GC, Bolanos JP, Heales SJR, and Clark JB. NO produced by activated astrocytes rapidly and reversibly inhibits cellular respiration. Neurosci Lett 193: 1-4, 1995[ISI][Medline].

7.   Brown, GC, and Cooper CE. Nanomolar concentrations of NO reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase. FEBS Lett 356: 295-298, 1994[ISI][Medline].

8.   Brown, GC, Foxwell N, and Moncada S. Transcellular regulation of cell respiration by NO generated by activated macrophages. FEBS Lett 439: 321-324, 1998[ISI][Medline].

9.   Cleeter, MWJ, Cooper JM, Darley-Usmar VM, Moncada S, and Schapira AHV Reversible inhibition of cytochrome oxidase, the terminal enzyme of the mitochondrial respiratory chain, by NO. FEBS Lett 345: 50-54, 1994[ISI][Medline].

10.   Clementi, E, Brown GC, Feelisch M, and Moncada S. Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective role of glutathione. Proc Natl Acad Sci USA 95: 7631-7636, 1998[Abstract/Free Full Text].

11.   Clementi, E, Brown GC, Foxwell N, and Moncada S. On the mechanisms by which vascular endothelial cells regulate their oxygen consumption. Proc Natl Acad Sci USA 96: 1559-1562, 1999[Abstract/Free Full Text].

12.   Geng, Y, Hansson GK, and Holme E. Interferon-gamma and tumor necrosis factor synergize to induce nitric oxide production and inhibit mitochondrial respiration in vascular smooth muscle cells. Circ Res 71: 1268-1276, 1992[Abstract/Free Full Text].

13.   Giuffre, A, Sarti P, D'Itri E, Buse G, Soulimane T, and Brunori M. On the mechanism of inhibition of cytochrome c oxidase by NO. J Biol Chem 271: 33404-33408, 1996[Abstract/Free Full Text].

14.   Heales, JR, Bolanos JP, Stewart VC, Brookes PS, Land JM, and Clark JB. NO, mitochondria and neurological disease. Biochim Biophys Acta 1410: 215-228, 1999[Medline].

15.   Hibbs, JJB, Taintor RR, Vavrin Z, and Rachlin EM. NO: a cytotoxic activated-macrophage effector molecule. Biochem Biophys Res Commun 157: 87-94, 1988[ISI][Medline].

16.   Ignarro, LJ. Introduction and overview. In: Nitric Oxide: Biology and Pathobiology. San Diego, CA: Academic, 2000, p. 3-19.

17.   Ishibashi, Y, Duncker DJ, Zhang J, and Bache RJ. ATP-sensitive K+ channels, adenosine, and NO-mediated mechanisms account for coronary vasodilation during exercise. Circ Res 82: 346-359, 1998[Abstract/Free Full Text].

18.   King, CE, Melinyshyn MJ, Mewburn JD, Curtis SE, Winn MJ, Cain SM, and Chapler CK. Canine hindlimb blood flow and oxygen uptake after inhibition of EDRF/NO synthesis. J Appl Physiol 76: 1166-1171, 1994[Abstract/Free Full Text].

19.   Laffranchi, R, Gogvadze V, Richter C, and Spinas GA. NO stimulates insulin secretion by inducing calcium release from mitochondria. Biochem Biophys Res Commun 217: 584-591, 1996.

20.   Lizasoain, I, Moro MA, Knowles RG, Darley-Usmar V, and Moncada S. Nitric oxide and peroxynitrite exert distinct effects on mitochondrial respiration which are differentially blocked by glutathione or glucose. Biochem J 314: 877-880, 1996.

21.   Loke, KE, Forfia PR, Recchia FA, Xu XB, Osorio JC, Ochoa M, Gawryl M, and Hintze TH. Bovine polymerized hemoglobin increases cardiac oxygen consumption and alters myocardial substrate metabolism in conscious dogs: role of nitric oxide. J Cardiovasc Pharmacol 35: 84-92, 2000[ISI][Medline].

22.   Loke, KE, McConnell PI, Tuzman JM, Shesely EG, Smith CJ, Stackpole CJ, Thompson CI, Kaley G, Wolin MS, and Hintze TH. Endogenous endothelial NO synthase-derived NO is a physiological regulator of myocardial oxygen consumption. Circ Res 84: 840-845, 1999[Abstract/Free Full Text].

23.   Moncada, S, Palmer RM, and Higgs EA. Nitric oxide: physiology, pathology, and pharmacology. Pharmacol Rev 43: 109-142, 1991[ISI][Medline].

24.   Orsi, A, Rees DD, Beltran B, and Moncada S. Physiological regulation and pathological inhibition of tissue respiration by nitric oxide in vivo. In: The Biology of Nitric Oxide, , edited by Moncada S, Gustafsson LE, Wiklund NP, and Higgs EA.. London: Portland, 2000, part 7, p. 35.

25.   Poderoso, JJ, Carreras MC, Lisdero C, Riobo N, Schopfer F, and Boveris A. NO inhibits electron transfer and increases superoxide radical production in rat heart mitochondria and submitochondrial particles. Arch Biophys Biochem 328: 85-92, 1996.

26.   Radi, R, Rodriguez M, Castro L, and Telleri R. Inhibition of mitochondrial electron transport by peroxynitrite. Arch Biochem Biophys 308: 89-95, 1994[ISI][Medline].

27.   Rees, DD, Cellek S, Palmer RM, and Moncada S. Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: an insight into endotoxin shock. Biochem Biophys Res Commun 173: 541-547, 1990[ISI][Medline].

28.   Rees, DD, Higgs EA, and Moncada S. Nitric oxide and the vessel wall. In: Hemostasis and Thrombosis, edited by Colman RW, Hirsh J, Marder VJ, Clowes AW, and George NJ.. Philadelphia, PA: Lippincott, Williams and Wilkins, 2000, p. 673-682.

29.   Rees, DD, Monkhouse JE, Cambridge D, and Moncada S. Nitric oxide and the haemodynamic profile of endotoxin shock in the conscious mouse. Br J Pharmacol 124: 540-546, 1998[ISI][Medline].

30.   Ruetten, H, and Thiemermann C. Nitric oxide and septic shock. In: Nitric oxide: Biology and Pathobiology. San Diego, CA: Academic, 2000, p. 747-757.

31.   Schweizer, M, and Richter C. NO potently and reversibly deenergizes mitochondria at low oxygen tension. Biochem Biophys Res Commun 204: 169-175, 1994[ISI][Medline].

32.   Singer, M, and Brealey D. Mitochondrial dysfunction in sepsis. Biochem Soc Symp 66: 149-166, 1999[Medline].

33.   Shen, W, Hintze TH, and Wolin MS. NO: an important signalling mechanism between vascular endothelium and parenchymal cells in the regulation of oxygen consumption. Circulation 92: 3505-3512, 1995[Abstract/Free Full Text].

34.   Shen, W, Xu X, Ochoa M, Zhoa G, Wolin MS, and Hintze TH. Role of NO in the regulation of oxygen consumption in conscious dogs. Circ Res 75: 1086-1095, 1994[Abstract/Free Full Text].

35.   Spitzer, JJ. Bacterial endotoxin effects on carbohydrate utilization and transport. Biochem Soc Trans 23: 998-1002, 1995[ISI][Medline].

36.   Stadler, J, Billiar TR, Curran RD, Stuehr DJ, Ochoa JB, and Simmons RL. Effect of exogenous and endogenous nitric oxide on mitochondrial respiration of rat hepatocytes. Am J Physiol Cell Physiol 260: C910-C916, 1991[Abstract/Free Full Text].

37.   Stuehr, DJ, and Nathan CF. NO: a macrophage product responsible for cytostasis and respiratory inhibition in tumour target cells. J Exp Med 169: 1543-1555, 1989[Abstract/Free Full Text].

38.   Szabo, C, Zingarelli B, and Salzman AL. Role of poly-ADP ribosyltransferase activation in the vascular contractile and energetic failure elicited by exogenous and endogenous nitric oxide and peroxynitrite. Circ Res 78: 1051-1063, 1996[Abstract/Free Full Text].

39.   Titheradge, MA. Nitric oxide in septic shock. Biochim Biophys Acta 1411: 437-455, 1999[Medline].

40.   Torres, J, Darley-Usmar V, and Wilson MT. Inhibition of cytochrome c oxidase in turnover by NO: mechanisms and implications for control of respiration. Biochem J 312: 169-173, 1995.

41.   Wolin, MS, Xie YW, and Hintze TH. Nitric oxide as a regulator of tissue oxygen consumption. Curr Opin Nephrol Hypertens 8: 97-103, 1999[ISI][Medline].

42.   Zhao, G, Bernstein RD, and Hintze TH. Nitric oxide and oxygen utilization: exercise, heart failure and diabetes. Coron Artery Dis 10: 315-320, 1999[ISI][Medline].


Am J Physiol Heart Circ Physiol 281(6):H2256-H2260
0363-6135/01 $5.00 Copyright © 2001 the American Physiological Society



This article has been cited by other articles:


Home page
Circ. Res.Home page
C. Nunez, V. M. Victor, R. Tur, A. Alvarez-Barrientos, S. Moncada, J. V. Esplugues, and P. D'Ocon
Discrepancies Between Nitroglycerin and NO-Releasing Drugs on Mitochondrial Oxygen Consumption, Vasoactivity, and the Release of NO
Circ. Res., November 11, 2005; 97(10): 1063 - 1069.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
E. A. L Gallagher, J. P Newman, L. R Green, and M. A Hanson
The effect of low protein diet in pregnancy on the development of brain metabolism in rat offspring
J. Physiol., October 15, 2005; 568(2): 553 - 558.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
X. Liu, C. Cheng, N. Zorko, S. Cronin, Y.-R. Chen, and J. L. Zweier
Biphasic modulation of vascular nitric oxide catabolism by oxygen
Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2421 - H2426.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Fiorucci, A. Mencarelli, E. Distrutti, M. Baldoni, P. del Soldato, and A. Morelli
Nitric Oxide Regulates Immune Cell Bioenergetic: A Mechanism to Understand Immunomodulatory Functions of Nitric Oxide-Releasing Anti-Inflammatory Drugs
J. Immunol., July 15, 2004; 173(2): 874 - 882.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. H. Hintze
Prologue: Nitric oxide-hormones, metabolism, and function
Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2253 - H2255.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (17)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Borutaite, V.
Right arrow Articles by Brown, G. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Borutaite, V.
Right arrow Articles by Brown, G. C.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online